Visualisation of Indocyanine Green in Primary and Interval Debulking for Ovarian Cancer
Status:
Enrolling by invitation
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Visualise peritoneal lesions of epithelial ovarian cancer (EOC) in both primary and interval
debulking surgery by using intravascular indocyanine green (ICG) and near-infrared (NIR)
light. This Trial wants to investigate whether ICG can increase the visibility of peritoneal
lesions and can differentiate between peritoneal implants and fibrosis.